A Randomized, Double-Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of EVO756 for the Prevention of Migraine in Adults
A Randomized, Double-Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of EVO756 for the Prevention of Migraine in Adults
This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.
Key Inclusion Criteria:
Key Exclusion Criteria:
nichole.baio@evommune.com(650) 319-4553
Chandler, Arizona 85286, United States
ClinicalResearch@TrialSphereAZ.com6232679314
Walnut Creek, California 94598, United States
Stamford, Connecticut 06905, United States
lflores@neuropain.com5594379700 ext. 316
jlatorre@clinicalri.net(323)879-9999
kabdullah@flourishresearch.com9259307267
annelise@neinh.com203-914-1903 ext. 142
bsagil@cnshealthcare.com904-281-5757
info@applemedresearch.org3056678434
orlinfo@cnshealthcare.com(407) 425-5100
ysanchez@vantagetrials.com8135495265
benoit.tete@accelclinical.com404-475-0552
research@mhni.com734-677-6000 ext. 4
jryan@bbhnj.com732-244-2299
abryan@dentinstitute.com716-250-2017
amberc@ashneuro.com(828) 210-9306
achambers@eximiaresearch.com(919) 800-5154
Info@clinicaltrialssc.com843-725-5067
ATXClinic@fstrials.com(512) 380-9925
dallasleads@fstrials.com214-361-7700
nichole.baio@evommune.com(832) 533-8872
research@vaughtneurology.com304-252-4222